Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration

Bidragets beskrivning

The delivery of therapeutic agents to the central nervous system remains a major challenge. This is especially true in neurodegenerative diseases. While significant discoveries have recently been made in the genetics of ALS/FTD, patients still have no real therapeutic treatments. Here we aim to boost the clinical translation of the preclinical research and assembled a multidisciplinary research team with complimentary expertise to (1) generate 3D in vitro multicellular organoid models from iPSCs derived from healthy and patients with ALS/FTD; (2) fully characterize the newly generated models using established assays in the consortium (e.g. molecular markers and electrophysiology); (3) explore mechanistic pathways in particular pro-inflammatory, anti-oxidant and DNA damage pathways and ultimately use the model for (4) drug and gene based therapeutic screening.
Visa mer

Startår

2020

Slutår

2023

Beviljade finansiering

Tarja Malm Orcid -palvelun logo
150 917 €

Finansiär

Finlands Akademi

Typ av finansiering

Kansainvälinen yhteisrahoitteinen ohjelma

Övriga uppgifter

Finansieringsbeslutets nummer

334801

Vetenskapsområden

Neurovetenskaper

Forskningsområden

Neurotiede

Identifierade teman

brain, neuroscience